RxDoctor Payments Data

Mark Ignatius, DO

Physical Medicine & Rehabilitation · San Francisco, CANPI 1073743233

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,949 of the $11,984 with a category attached, or 66.3%. 9 manufacturers reported payments, led by GRT US Holding, Inc. at 34.6% of the total. Reporting peaked in 2019 at $4,731 and has fallen 66.8% since, to $1,572 in 2025. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,984in general payments, 2019–2025

Across 79 payments — averaging $151.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GRT US Holding, Inc.$4K
  • Biotronik NRO, Inc.$3K
  • Abbott$2K
  • Bioventus LLC$2K
  • Medtronic$167
  • Boston Scientific$160
  • plus $183 from 3 others

What the payments were for

  • Speaking & faculty fees$4,00033%
  • Travel & lodging$350%
  • Food & beverage$7,94966%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GRT US Holding, Inc.4$4,148
Biotronik NRO, Inc.30$3,288
Abbott24$2,412
Bioventus LLC15$1,626
Medtronic1$167
Boston Scientific2$160
The Cameron-ehlen Group, Inc.1$136
Vertex1$28
Mallinckrodt Enterprises LLC1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,984 in reported general payments places this provider in the 95th percentile of 830 physical medicine & rehabilitation providers in California.

See all physical medicine & rehabilitation providers in California

Medicare billing

Part B allowed, 2024
$229,006
Medicare patients
607
Services billed
4,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin166$2,529
Celecoxib64$1,281
Tizanidine Hcl30$416
Diclofenac Sodium15$211

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →